- Lobbying
- Alanna AND Porter
Lobbying Arrangements Results for 'Alanna Porter'
Former Covered Federal Workers:
Other Lobbyists:
Issue | Client | Firm | Lobbyists | Start Date | Latest Filing Date |
---|---|---|---|---|---|
Details Prescription Drug Competition Issues. H.R.4692/S.574 - Increasing Prescription Drug Competition Act. |
Avadel Pharmaceuticals, plc
|
LMH STRATEGIC SOLUTIONS | |||
Details Access for inpatient gene therapies. Monitor newborn screening issues. H.R.2666 - MVP Act. |
Orchard Therapeutics North America
|
LMH STRATEGIC SOLUTIONS | |||
Details General Medicare and Medicaid Issues. Prescription drug payment reform. Drug Pricing and Access. Pharmaceutical Supply Chain. Pharmacy Benefit Managers. |
Pharmaceutical Research and Manufacturers of America
|
LMH STRATEGIC SOLUTIONS | |||
Details Health programs impacting MDMA. H.R.1691 - Ensuring Patient Access to Critical Breakthrough Products Act of 2023, Ethylene Oxide (EtO), TCET. |
Medical Device Manufacturers Association
|
LMH STRATEGIC SOLUTIONS | |||
Details General health industry issues and pharmaceutical issues impacting GSK. |
GlaxoSmithKline LLC
Pharmaceutical Company. |
LMH STRATEGIC SOLUTIONS | |||
Details Medicare Parts B and D drugs payments and access. |
ALLERGAN, INC.
|
THE MCMANUS GROUP | |||
Details Issues related to access to and development of domestic rare mineral resources. |
Red Flat Nickel Corporation
|
THE MCMANUS GROUP | |||
Details Implementation of provisions included in Subtitle BB of PL. 116-260 - No Surprises Act. |
Pediatrix Medical Group (MEDNAX National Medical Group)
|
THE MCMANUS GROUP | |||
Details Medicare issues as they relate to oncology and multi-cancer early detection, including diagnostics and screening, H.R.2407 - Nancy Gardner Sewell Medicare Multi-Cancer Early Detection Screening Cov... |
GRAIL, INC.
|
THE MCMANUS GROUP | |||
Details Access and coverage of inpatient drugs in H.R. 2666 - Medicaid VBPs for Patients (MVP) Act. Education and awareness of rare and ultra rare diseases and patient access to orphan drugs. Education an... |
Orchard Therapeutics North America
|
THE MCMANUS GROUP | |||
Details Implementation of provisions included in Subtitle B of PL. 117-169 - Inflation Reduction Act of 2022 Access and coverage of inpatient drugs in Medicaid program (H.R. 2666- Medicaid VBPs for Patien... |
PTC Therapeutics Inc.
|
THE MCMANUS GROUP | |||
Details Education and advocacy regarding emergency services and Medicare reimbursement of freestanding emergency centers including H.R.1694 - Emergency Care Improvement Act. Implementation of provisions in... |
National Association of Freestanding Emergency Centers (NAFEC)
|
THE MCMANUS GROUP | |||
Details Access and reimbursement in Medicare Parts B & D. Implementation of provisions included in Subtitle B of PL. 117-169 - Inflation Reduction Act of 2022. Issues related to the reauthorization of th... |
Alkermes, Inc.
|
THE MCMANUS GROUP | |||
Details Access and reimbursement of drugs in Medicare Parts B and D. Implementation of provisions included in Subtitle B of PL. 117-169 - Inflation Reduction Act of 2022 Issues related to reforming and i... |
Gilead Sciences, Inc.
|
THE MCMANUS GROUP | |||
Details Issues related health savings accounts (HSAs) and individual coverage health reimbursement arrangements (ICHRAs) including in H.R.3799 - CHOICE Arrangement Act. H.R. 5688, the Bipartisan HSA Impro... |
WEX Health
|
THE MCMANUS GROUP | |||
Details Access and reimbursement for Part B and Part D drugs. Advocating for access to biosimilars. Implementation of provisions included in Subtitle B of PL. 117-169 - Inflation Reduction Act of 2022. ... |
AMGEN
|
THE MCMANUS GROUP | |||
Details Access to DME-infused drugs in the home, H.R. 5397, the Joe Fiandra Access to Home Infusion Act of 2023 (Reps. Fitzpatrick and Dunn) Implementation of provisions included in Subtitle B of PL. 11... |
Alnylam Pharmaceuticals
|
THE MCMANUS GROUP | |||
Details Implementation of provisions included in Subtitle B of PL. 117-169 - Inflation Reduction Act of 2022 Policies to remove barriers to physician prescribing decisions including in H.R. 2630/S.652 - Sa... |
Horizon Therapeutics USA, Inc. (formerly known as Horizon Pharma USA, Inc.)
|
THE MCMANUS GROUP | |||
Details Access and reimbursement of medical devices in Medicare program. Access and reimbursement of medical devices in Medicare program including in H.R.1691 - Ensuring Patient Access to Critical Breakth... |
Zimmer Biomet
|
THE MCMANUS GROUP | |||
Details Increased patient access and reimbursement to procedures in ambulatory surgical centers including in H.R. 972/S. 312 - Outpatient Surgery Quality and Access Act of 2023. Site neutrality provisions... |
Ambulatory Surgery Center Association
|
THE MCMANUS GROUP | |||
Details Continued access to occupational therapy services including in the Stabilizing Medicare Access to Rehabilitation and Therapy (SMART) Act. Continued expansion of telehealth services in H.R. 3875, S... |
American Occupational Therapy Association
|
THE MCMANUS GROUP | |||
Details Access to autologous cellular immunotherapies in Medicare Part B. Implementation of provisions included in Subtitle B of PL. 117-169 - Inflation Reduction Act of 2022 Support for H.R.1826, S.2821 ... |
Dendreon Pharmaceuticals LLC
|
THE MCMANUS GROUP | |||
Details Access and reimbursement of medical devices in Medicare program including in H.R.1691 - Ensuring Patient Access to Critical Breakthrough Products Act of 2023. Issues related to Transitional Covera... |
MEDICAL DEVICE MANUFACTURERS ASSOCIATION
|
THE MCMANUS GROUP | |||
Details N/A HR 3502, Protecting People from Surprise Medical Bills Act |
AMERICAN ACADEMY OF ORTHOPAEDIC SURGEONS
|
in-house lobbying | |||
Details Medicare Part B reform. S. 2543, the Prescription Drug Pricing Reduction Act of 2019, and H.R. 19/ S.3129, the Lower Costs, More Cures Act of 2019. International Pricing Index model (83 FR 54546). ... |
IVX Health
|
THE MCMANUS GROUP | |||
Details Implementation of provisions included in Subtitle B of PL. 117-169 - Inflation Reduction Act of 2022. Issues related to down coding of certain complex Part B drugs by regional Medicare Administrat... |
Infusion Providers Alliance
|
THE MCMANUS GROUP | |||
Details General pharmaceutical coverage and reimbursement issues, issues and activities affecting oncology, neurodegenerative and fertility products. Issues related to reforming and increasing transparenc... |
EMD Serono, Inc.
|
THE MCMANUS GROUP | |||
Details Access and reimbursement in Medicare Parts B & D. Implementation of provisions included in Subtitle B of PL. 117-169 - Inflation Reduction Act of 2022. H.R.2880 - Protecting Patients Against PBM... |
PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA
|
THE MCMANUS GROUP | |||
Details Access and reimbursement of Part B Drugs in Medicare. Continued expansion of Telehealth services including in the H.R. 3857 - Expanded Telehealth Access Act and Telehealth Modernization Act. H.R.... |
Digestive Health Physicians Association, Inc.
|
THE MCMANUS GROUP | |||
Details Access and reimbursement in Medicare Parts B and D. Implementation of provisions included in Subtitle B of PL. 117-169 - Inflation Reduction Act of 2022. S. 2764/H.R.5391 - Protecting Patient Ac... |
GENENTECH
|
THE MCMANUS GROUP | |||
Details H.R. 1730, Cancer Drug Parity Act, regarding all provisions. S. 741, Cancer Drug Parity Act,regarding all provisions. H.R. 2279, Safe Step Act, issues relating to Step Therapy / Fail First. HR 9... |
CELGENE CORPORATION
|
in-house lobbying | |||
Details HR 2474: Strengthening Medicare for Patients and Providers Act. Reps. Raul Ruiz, MD (D-CA); Larry Bucshon, MD (R-IN); Ami Bera, MD (D-CA); Mariannette Miller-Meeks, MD (R-IA) Provides an annual Me... |
AMERICAN ASSOCIATION OF ORTHOPAEDIC SURGEONS
|
in-house lobbying | |||
Details HR 547: Better Care Better Jobs Act; all provisions of the bill HR 830:Help Ensure Lower Patient (HELP) Copays Act; all provisions of the bill HR 2534: Preserving Rules Ordered for The Entities C... |
EMD SERONO, INC.
|
in-house lobbying |